Upgrade to Finviz Elite: Get our fastest platform speed, real-time data, and unlimited screening & charting. Start Free Trial

PRQR

ProQR Therapeutics N.V

May 27 • 10:12AM ET

1.62

+0.04 2.87 %

Healthcare • Biotechnology • Netherlands • Micro • NASD

Peers: WVE QURE ARWR EDIT VYGR

| Held by: QQQS

Scroll to Statements

Index	-	P/E	-	EPS (ttm)	-0.50	Insider Own	32.21%	Shs Outstand	105.36M	Perf Week	12.94%
Market Cap	170.16M	Forward P/E	-	EPS next Y	-0.69	Insider Trans	0.00%	Shs Float	71.43M	Perf Month	8.39%
Enterprise Value	92.50M	PEG	-	EPS next Q	-0.14	Inst Own	34.03%	Short Float	1.18%	Perf Quarter	4.87%
Income	-52.71M	P/S	10.96	EPS this Y	-27.95%	Inst Trans	-2.10%	Short Ratio	1.43	Perf Half Y	-21.60%
Sales	15.53M	P/B	3.93	EPS next Y	-15.81%	ROA	-37.92%	Short Interest	0.84M	Perf YTD	-20.05%
Book/sh	0.41	P/C	1.82	EPS next 5Y	9.54%	ROE	-81.98%	52W High	3.10 -47.90%	Perf Year	-5.00%
Cash/sh	0.89	P/FCF	-	EPS past 3/5Y	21.80% 15.68%	ROIC	-98.02%	52W Low	1.33 21.43%	Perf 3Y	-5.83%
Dividend Est.	-	EV/EBITDA	-	Sales past 3/5Y	68.13% -	Gross Margin	79.71%	Volatility	7.00% 7.98%	Perf 5Y	-73.08%
Dividend TTM	-	EV/Sales	5.96	EPS Y/Y TTM	-44.36%	Oper. Margin	-346.94%	ATR (14)	0.12	Perf 10Y	-66.70%
Dividend Ex-Date	-	Quick Ratio	2.48	Sales Y/Y TTM	-23.73%	Profit Margin	-339.39%	RSI (14)	51.22	Recom	1.00
Dividend Gr. 3/5Y	- -	Current Ratio	2.48	EPS Q/Q	-47.57%	SMA20	2.49%	Beta	0.07	Target Price	8.95
Payout	-	Debt/Eq	0.36	Sales Q/Q	-49.99%	SMA50	-2.17%	Rel Volume	0.78	Prev Close	1.57
Employees	-	LT Debt/Eq	0.24	Earnings	May 12 BMO	SMA200	-17.75%	Avg Volume	591.88K	Price	1.62
IPO	Sep 18, 2014	Option/Short	Yes / Yes	EPS/Sales Surpr.	-9.12% -54.37%	Trades		Volume	71,755	Change	2.87%

Affiliate • Advertise • Careers • Contact • Blog • Help • Privacy • Follow us on X • Do Not Sell My Personal Information

Quotes delayed 15 minutes for NASDAQ, NYSE and AMEX.
Copyright © 2007-2026 Finviz.com. All Rights Reserved. Export All Screener Data (CSV)